Malaria is common in areas such as Africa, South America, and Southern Asia. This medicine is not effective against all strains of malaria. Precaution of chloroquine Reactions to plaquenil Chloroquine lysotracker Anti-malarial drugs hydroxychloroquine, chloroquine are considered pregnancy category C drugs. While there is evidence of risk for damage to the eye and ear, if the benefits of these drugs in controlling RA symptoms are judged to outweigh the risks, they may continue to be used during pregnancy. 1,2 Patient teaching • Advise patient to take with food or milk. ☞ Instruct patient to immediately report such adverse reactions as vision changes, nausea, vomiting, drowsiness, mental changes, mood swings, headache, ringing in ears, muscle weakness, rash, bleeding, bruising, and yellowing of skin and eyes. Hydroxychloroquine Pregnancy Warnings Animal studies have revealed evidence of fetal harm. Use of chloroquine and other 4-aminoquinolines in high doses and for prolonged durations has been associated with neurological disturbances and interference with hearing, balance, and vision in the fetus. Taking hydroxychloroquine long-term or at high doses may cause irreversible damage to the retina of your eye. Hydroxychloroquine is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. Hydroxychloroquine sulfate pregnancy category Hydroxychloroquine sulfate - GLOWM, Hydroxychloroquine sulfate definition of hydroxychloroquine. Plaquenil dosage for lyme diseaseHydroxychloroquine side effects clinial studiesHydroxychloroquine myositis To study maternal and fetal outcome of pregnancy in patients with lupus who were exposed to hydroxychloroquine HCQ. The case records of women n = 33 exposed to HCQ during their pregnancies n. PDF Hydroxychloroquine and lupus pregnancy Review of a.. Hydroxychloroquine Use During Pregnancy. Precautions and Warnings With Hydroxychloroquine. Availability. 200 mg tablets. Actions. Derivative closely related to chloroquine. Antimalarial activity is believed to be based on ability to form complexes with DNA of parasite, thereby inhibiting replication and transcription to RNA and DNA synthesis of the parasite. In every pregnancy, a woman starts out with a 3-5% chance of having a baby with a birth defect. This is called her background risk. This sheet talks about whether exposure to hydroxychloroquine may increase the risk for birth defects over that background risk. The full risks of using Plaquenil hydroxychloroquine during pregnancy are not known at this time. This eMedTV segment includes more information on Plaquenil and pregnancy, and explains whether the drug is likely to affect a fetus.